Toggle Nav
My Cart
Search
Menu
Account
Settings
Healthcare Technology Advances in Senolytics

Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells

INDUSTRY
Healthcare

RELEASE DATE
02-May-2023
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
DA8D-01-00-00-00
SKU
HC03663-GL-TR_27614
Yes
SHARE

Technology Advances in Senolytics
Published on: 02-May-2023 | SKU: HC03663-GL-TR_27614

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Request Sample
Add to Compare
Need more details?
Description

Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the body) but remain metabolically active after a senescence-associated secretory phenotype (SASP) change, which leads to disease conditions.

The youngest baby boomers will be over the age of 65 in 2029, just 6 years away, which suggests an expanding economic burden related to this population, considering the cost of healthcare, caregivers, palliative care, health insurance, and other care-related activities. This wave of baby boomers makes it essential to address chronic diseases at their onset through senotherapeutics, with senolytics being such a method.

Senotherapeutic drug development suffered a few minor hiccups in the early days of research. For instance, in 2020, one new drug failed at inception after investors had contributed significant funding. However, constant research has resulted in a few possible opportunities that have rekindled interest in this area. It is imperative to track developments in this space to understand the progress of pharmaceuticals, nutraceuticals, and other emerging opportunities. This is a compelling space to watch for investments and research.

This research identifies the various drugs, modalities, development approaches, technology advancements, nutraceutical growth, opportunities for their translation to over-the counter (OTC) treatments, as well as the challenges that still require addressing. In addition, the study highlights the immediate R&D needs and innovations likely to emerge in the next 5 years, and it sheds light on developments regarding mergers and acquisitions (M&As), partnerships, licensing, funding, and opportunity areas for growth.

Infographic
Table of Contents

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Senolytics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Research Context and Scope of Analysis

Segmentation

Growth Drivers

Growth Restraints

The Need for Senotherapeutics

Senolytics Are Emerging as a Promising Class of Senotherapeutics

Benefits of Senolytics over Other Senotherapeutics

Senolytic Drug Development Timeline

Senolytics—A Novel Approach to Healthcare, Presents Interesting Opportunities and Challenges

Successes, Opportunities, and Failures in Senolytic Drug Discovery

Promising R&D Prospects in Senolytics

Things to Know about Senolytic Drug Development

Approaches to Target Sncs Increase R&D Opportunities and Success Possibilities

Targets, Drugs, and Modalities under Investigation to Develop Senolytic Drugs

Anti-apoptotic Pathways Are a Highly Explored Area for Senolytics

Targeting Anti-apoptotic Pathways Is a Common Approach to Senolytic Drugs

Tackling Newer Targets Is an Emerging Approach

Therapies Targeting Various Physiologies and Pathways

Small Molecule Senolytics

Biologics under Development for Senolytics

Cell and Gene Therapies under Development for Senolytics

Approaches to Improve the Senolytic Drug Development Process

Players in the Senolytic Drug Development Field

Natural Products Can Potentially Translate to Senolytics

Naturally Derived Senolytics and Commercial Developments

Opportunities and Recent Advancements in Naturally Derived Senolytics

Continuous Innovations Will Shape the Senolytic Drug Development Industry during the Next 5 Years

Outlook for Senolytic Drug Development

Senolytic Drug Technology Enablers

Emerging Technologies for Senolytic Drug Development and Diagnostics

Biomarkers Play a Vital Role in the Senotherapeutic Industry

Efforts to Discover a Universal SNC Biomarker

AI-assisted Advances in Drug Discovery and Diagnostics

Financial Growth, M&As, Partnership Trends, and New Entrants Are Evident in the Young Field of Senolytics

A Conducive Funding Environment, an Active R&D Space, and the Significant Contribution of AI Drive Senolytic Drug Development

Completed M&As and Proposed Mergers to Look Forward to in 2023

Partnerships in Senolytic Drug Discovery and Development Skew Toward AI

Partnerships in Senolytic Drug Discovery and Development Skew Toward AI (continued)

Drug and Technology Licensing and IPOs by Senolytic Developing Companies Will Increase

Spin-off Companies Developing Senolytic Drugs Are on the Increase

Conducive Grants and Research Funding Support Senotherapeutics

Funding Analysis in the Senolytic Drug Development Industry

Growth Opportunity 1: Growing Involvement of Large Pharma Companies

Growth Opportunity 1: Growing Involvement of Large Pharma Companies (continued)

Growth Opportunity 2: Development of New Biomarkers to Aid in Drug Discovery

Growth Opportunity 2: Development of New Biomarkers to Aid in Drug Discovery (continued)

Growth Opportunity 3: Convergence Opportunities Between Drug Development Companies

Growth Opportunity 3: Convergence Opportunities Between Drug Development Companies (continued)

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer

Request Sample

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

06 Oct 2026   |   Global   |   Technology Research

Trends in Laboratory Automation, Global, 2021–2025

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...

05 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026

The point-of-care ultrasound imaging industry is undergoing a fundamental transformation from equipment-intensive ultrasound to portable, handheld, wireless, AI-enabled, and connected point-of-care solutions. Driven by the need for rapid bedside diagnosis and decentralized healthcare delivery, speci...

25 Sep 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...

23 Sep 2026   |   Global   |   Technology Research

Programmable Epigenome Editing for Disease Reversal

Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...

21 Sep 2026   |   Europe   |   Market Research

HLTH Europe 2026: Five Key Takeaways and Growth Opportunities

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts
Related Research
  1. Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
    Release Date: 17-Apr-26
  2. Global Healthcare IT Investment Growth Opportunities, 2026
    Release Date: 20-Jan-26
  3. Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
    Release Date: 17-Jul-26
  4. Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
    Release Date: 23-Jan-26
  5. Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
    Release Date: 19-Jun-26

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the body) but remain metabolically active after a senescence-associated secretory phenotype (SASP) change, which leads to disease conditions. The youngest baby boomers will be over the age of 65 in 2029, just 6 years away, which suggests an expanding economic burden related to this population, considering the cost of healthcare, caregivers, palliative care, health insurance, and other care-related activities. This wave of baby boomers makes it essential to address chronic diseases at their onset through senotherapeutics, with senolytics being such a method. Senotherapeutic drug development suffered a few minor hiccups in the early days of research. For instance, in 2020, one new drug failed at inception after investors had contributed significant funding. However, constant research has resulted in a few possible opportunities that have rekindled interest in this area. It is imperative to track developments in this space to understand the progress of pharmaceuticals, nutraceuticals, and other emerging opportunities. This is a compelling space to watch for investments and research. This research identifies the various drugs, modalities, development approaches, technology advancements, nutraceutical growth, opportunities for their translation to over-the counter (OTC) treatments, as well as the challenges that still require addressing. In addition, the study highlights the immediate R&D needs and innovations likely to emerge in the next 5 years, and it sheds light on developments regarding mergers and acquisitions (M&As), partnerships, licensing, funding, and opportunity areas for growth.
More Information
Deliverable Type Technology Research
Author Lonita lawrence
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Senolytics Market
Keyword 2 Technology Advances in Senolytics
Keyword 3 Senotherapeutic drug development
Podcast No
WIP Number DA8D-01-00-00-00

Technology Advances in Senolytics

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03663-GL-TR_27614